Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Suleimen Zhumatayev"'
Autor:
Suleimen Zhumatayev, Koray Yalcin, Safiye Suna Celen, Vedat Uygun, Gulsun Karasu, Mehmet Akif Yesilipek
Publikováno v:
Clinical Pediatric Hematology-Oncology, Vol 31, Iss 1, Pp 10-13 (2024)
Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children, with a particularly poor prognosis in infants under one year of age. Hematopoietic stem cell transplantation (HSCT) is an effective therapy for relapsed or refractory A
Externí odkaz:
https://doaj.org/article/09b9b75c23f54e589f0d05641243d68c
Autor:
Koray Yalçın, Dayanat Pashayev, Suna Çelen, Suleimen Zhumatayev, Gülsün Karasu, Vedat Uygun, Volkan Hazar, Akif Yeşilipek
Publikováno v:
Journal of Pediatric Research, Vol 9, Iss 3, Pp 208-213 (2022)
Aim:In hematopoietic stem cell transplantation (HSCT), the phase of engraftment which can be described as an “immunogenic storm”, is also vulnerable to infections and it has been always very hard to discriminate the cause of fever in this special
Externí odkaz:
https://doaj.org/article/cc6745d8ee3b40ed987ebdea08986578
Autor:
Koray Yalcin, Hatice Turanoglu, Aysenur Gencalp, Mustafa Kemal Demir, Safiye Suna Celen, Suleimen Zhumatayev, Gulsun Karasu
Publikováno v:
Indian Journal of Pediatrics. 89:1156-1156
Autor:
Hayriye Daloğlu, Dayanat Pashayev, Suna Celen, Akif Yesilipek, Seda Öztürkmen, Koray Yalcin, Vedat Uygun, Gülsün Karasu, Suleimen Zhumatayev
Publikováno v:
Clinical transplantationREFERENCES. 35(7)
Objective The selection of graft-vs. -host disease (GvHD) prophylaxis is vital for the success of hematopoetic stem cell transplantation (HSCT), and calcineurin inhibitors (CNI) have been used for decades as the backbone of GvHD prophylaxis. The aim
Autor:
Hayriye Daloğlu, Akif Yesilipek, Vedat Uygun, Gulsun Karasu, Dayanat Pasayev, Suleimen Zhumatayev, Koray Yalcin, Volkan Hazar, Mustafa Kemal Demir, Seda Öztürkmen, Suna Celen
Publikováno v:
Pediatric Transplantation. 25
BACKGROUND ALD is a rare X-linked peroxisomal metabolic disorder with many distinct phenotypes of disease that emerge on a wide scale from adrenal insufficiency to fatal cALD which progresses to a vegetative state within a few years. Currently, HSCT